Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 4
Submit an article Journal homepage
1,657
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells

Karthikeyan SubbarayanInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, 06112 Halle/ Saale, GermanyView further author information
,
Sandra LeiszInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, 06112 Halle/ Saale, GermanyView further author information
,
Claudia WickenhauserInstitute of Pathology, Martin Luther University Halle-Wittenberg, 06112 Halle/ Saale, GermanyView further author information
,
Daniel BethmannInstitute of Pathology, Martin Luther University Halle-Wittenberg, 06112 Halle/ Saale, GermanyView further author information
,
Chiara MassaInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, 06112 Halle/ Saale, GermanyView further author information
,
André StevenInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, 06112 Halle/ Saale, GermanyView further author information
&
Barbara SeligerInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, 06112 Halle/ Saale, GermanyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5544-4958View further author information
ORCID Icon show all
Article: e1373233 | Received 31 Mar 2017, Accepted 25 Aug 2017, Published online: 16 Jan 2018

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Christoforos K. Vaxevanis, Marcus Bauer, Karthikeyan Subbarayan, Michael Friedrich, Chiara Massa, Katharina Biehl, Haifa Kathrin Al-Ali, Claudia Wickenhauser & Barbara Seliger. (2023) Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy. OncoImmunology 12:1.
Read now
Karthikeyan Subbarayan, Chiara Massa, Sandra Leisz, André Steven, Daniel Bethmann, Katharina Biehl, Claudia Wickenhauser & Barbara Seliger. (2022) Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells. OncoImmunology 11:1.
Read now

Articles from other publishers (13)

Kanakaraju Manupati, Ritama Paul, Mingang Hao, Michael Haas, Zhaoqun Christine Bian, Tammy M. Holm, Jun-Lin Guan & Syn Kok Yeo. (2022) Biglycan Promotes Cancer Stem Cell Properties, NFκB Signaling and Metastatic Potential in Breast Cancer Cells. Cancers 14:2, pages 455.
Crossref
Zi-Xuan He, Sheng-Bing Zhao, Xue Fang, Ji-Fu E, Hong-Yu Fu, Yi-Hang Song, Jia-Yi Wu, Peng Pan, Lun Gu, Tian Xia, Yi-Long Liu, Zhao-Shen Li, Shu-Ling Wang & Yu Bai. (2022) Prognostic and Predictive Value of BGN in Colon Cancer Outcomes and Response to Immunotherapy. Frontiers in Oncology 11.
Crossref
Valentina Diehl, Lisa Sophie Huber, Jonel Trebicka, Malgorzata Wygrecka, Renato V. Iozzo & Liliana Schaefer. (2021) The Role of Decorin and Biglycan Signaling in Tumorigenesis. Frontiers in Oncology 11.
Crossref
Yingying He, Tao Liu, Shuang Dai, Zihan Xu, Li Wang & Feng Luo. (2021) Tumor-Associated Extracellular Matrix: How to Be a Potential Aide to Anti-tumor Immunotherapy?. Frontiers in Cell and Developmental Biology 9.
Crossref
Gina Reye, Xuan Huang, Larisa M. Haupt, Ryan J. Murphy, Jason J. Northey, Erik W. Thompson, Konstantin I. Momot & Honor J. Hugo. (2021) Mechanical Pressure Driving Proteoglycan Expression in Mammographic Density: a Self-perpetuating Cycle?. Journal of Mammary Gland Biology and Neoplasia 26:3, pages 277-296.
Crossref
Xia Deng, Yanyan Li, Chang Guo, Zhicong Zhao & Guoyue Yuan. (2021) Novel roles of Tsukushi in signaling pathways and multiple disease processes. BioFactors 47:4, pages 512-521.
Crossref
Nikita Kotlov, Alexander Bagaev, Maria V. Revuelta, Jude M. Phillip, Maria Teresa Cacciapuoti, Zoya Antysheva, Viktor Svekolkin, Ekaterina Tikhonova, Natalia Miheecheva, Natalia Kuzkina, Grigorii Nos, Fabrizio Tabbo, Felix Frenkel, Paola Ghione, Maria Tsiper, Nava Almog, Nathan Fowler, Ari M. Melnick, John P. Leonard, Giorgio Inghirami & Leandro Cerchietti. (2021) Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures. Cancer Discovery 11:6, pages 1468-1489.
Crossref
Karthikeyan Subbarayan, Chiara Massa, Maria‐Filothei Lazaridou, Kamatchi Ulagappan & Barbara Seliger. (2021) Identification of a novel miR‐21‐3p/TGF‐β signaling‐driven immune escape via the MHC class I/biglycan axis in tumor cells. Clinical and Translational Medicine 11:3.
Crossref
Xiaowei Chen, Xin Li, Xueju Hu, Fei Jiang, Yan Shen, Rui Xu, Leilei Wu, Pingmin Wei & Xiaobing Shen. (2020) LUM Expression and Its Prognostic Significance in Gastric Cancer. Frontiers in Oncology 10.
Crossref
Heiko Roedig, Roxana Damiescu, Jinyang Zeng-Brouwers, Iva Kutija, Jonel Trebicka, Malgorzata Wygrecka & Liliana Schaefer. (2020) Danger matrix molecules orchestrate CD14/CD44 signaling in cancer development. Seminars in Cancer Biology 62, pages 31-47.
Crossref
Barbara Seliger & Soldano Ferrone. 2020. Biomarkers for Immunotherapy of Cancer. Biomarkers for Immunotherapy of Cancer 325 350 .
Michael Friedrich, Simon Jasinski-Bergner, Maria-Filothei Lazaridou, Karthikeyan Subbarayan, Chiara Massa, Sandy Tretbar, Anja Mueller, Diana Handke, Katharina Biehl, Jürgen Bukur, Marco Donia, Ofer Mandelboim & Barbara Seliger. (2019) Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy. Cancer Immunology, Immunotherapy 68:10, pages 1689-1700.
Crossref
Sandeep Appunni, Vivek Anand, Madhuram Khandelwal, Nidhi Gupta, Muni Rubens & Alpana Sharma. (2019) Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancer. Clinica Chimica Acta 491, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.